Home
Avoro Capital Advisors reported a 4.44% stake in Avalo Therapeutics AVTX · 2,333,333 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.44%
- Last report
- 5.75% · filed 26/05/15
- Shares held
- 2,333,333 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Avoro Capital Advisors
- Event date
- 26/06/30
- Filed
- 26/08/14
4.44% stake · below 5%
- Stake
- 4.44%
- Last report
- 5.75%
- Since last report
- −1.3pp
Avalo Therapeutics trades, last 26 weeks
What else happened in Avalo Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Avoro Capital Advisors's other 5% stake reports
- Avoro Capital Advisors
5% stakeHemab Therapeutics Holdings
5% stakeHemab Therapeutics Holdings
COAG
7.06% stake
3,298,236 sh
7.06% stake
Filed 08/14
- Avoro Capital Advisors
5% stakeArrowhead Pharmaceuticals
5% stakeArrowhead Pharmaceuticals
ARWR
9.64% stake
13,823,383 sh
9.64% stake
Filed 08/14
- Avoro Capital Advisors
5% stakeScribe Therapeutics
5% stakeScribe Therapeutics
SCTX
16.37% stake
3,088,888 sh
16.37% stake
Filed 07/30
- Avoro Capital Advisors
5% stakeDamora Therapeutics
5% stakeDamora Therapeutics
DMRA
6.27% stake
3,783,000 sh
6.27% stake
Filed 05/15
- Avoro Capital Advisors
5% stakeAvalo Therapeutics
5% stakeAvalo Therapeutics
AVTX
5.75% stake
1,410,000 sh
5.75% stake
Filed 05/15
